Predominantly Classic CNV: Treated With Visudyne Therapy

Скачать презентацию Predominantly Classic CNV:  Treated With Visudyne Therapy Скачать презентацию Predominantly Classic CNV: Treated With Visudyne Therapy

case_05_treated_predom_classic_cnv.ppt

  • Размер: 6.4 Мб
  • Автор:
  • Количество слайдов: 19

Описание презентации Predominantly Classic CNV: Treated With Visudyne Therapy по слайдам

Predominantly Classic CNV:  Treated With Visudyne Therapy Predominantly Classic CNV: Treated With Visudyne Therapy

Case Notes 81 -year-old female patient – Right eye VA was 0. 2 (20/100)Case Notes 81 -year-old female patient – Right eye VA was 0. 2 (20/100) Treated 3 times at three-month intervals

Baseline:  Color Fundus Photograph Case courtesy of M Stur Baseline: Color Fundus Photograph Case courtesy of M Stur

Baseline: Early-phase Fluorescein Angiogram Case courtesy of M Stur Baseline: Early-phase Fluorescein Angiogram Case courtesy of M Stur

Baseline: Mid-phase Fluorescein Angiogram Case courtesy of M Stur Baseline: Mid-phase Fluorescein Angiogram Case courtesy of M Stur

Baseline:  Mid–late-phase Fluorescein Angiogram Case courtesy of M Stur Baseline: Mid–late-phase Fluorescein Angiogram Case courtesy of M Stur

Baseline: Late-phase Fluorescein Angiogram Case courtesy of M Stur Baseline: Late-phase Fluorescein Angiogram Case courtesy of M Stur

3 -Month Follow-up: Color Fundus Photograph Case courtesy of M Stur 3 -Month Follow-up: Color Fundus Photograph Case courtesy of M Stur

3 -Month Follow-up:  Early-phase Fluorescein Angiogram Case courtesy of M Stur 3 -Month Follow-up: Early-phase Fluorescein Angiogram Case courtesy of M Stur

3 -Month Follow-up:  Early–mid-phase Fluorescein Angiogram Case courtesy of M Stur 3 -Month Follow-up: Early–mid-phase Fluorescein Angiogram Case courtesy of M Stur

3 -Month Follow-up:  Mid-phase Fluorescein Angiogram Case courtesy of M Stur 3 -Month Follow-up: Mid-phase Fluorescein Angiogram Case courtesy of M Stur

3 -Month Follow-up:  Late-phase Fluorescein Angiogram Case courtesy of M Stur 3 -Month Follow-up: Late-phase Fluorescein Angiogram Case courtesy of M Stur

3 -Month Follow-up:  Later-phase Fluorescein Angiogram Case courtesy of M Stur 3 -Month Follow-up: Later-phase Fluorescein Angiogram Case courtesy of M Stur

6 -Month Follow-up: Color Fundus Photograph Case courtesy of M Stur 6 -Month Follow-up: Color Fundus Photograph Case courtesy of M Stur

6 -Month Follow-up: Early-phase Fluorescein Angiogram Case courtesy of M Stur 6 -Month Follow-up: Early-phase Fluorescein Angiogram Case courtesy of M Stur

6 -month Follow-up: Mid-phase Fluorescein Angiogram Case courtesy of M Stur 6 -month Follow-up: Mid-phase Fluorescein Angiogram Case courtesy of M Stur

6 -Month Follow-up: Mid–late-phase Fluorescein Angiogram Case courtesy of M Stur 6 -Month Follow-up: Mid–late-phase Fluorescein Angiogram Case courtesy of M Stur

6 -Month Follow-up: Mid–late-phase Fluorescein Angiogram Case courtesy of M Stur 6 -Month Follow-up: Mid–late-phase Fluorescein Angiogram Case courtesy of M Stur

6 -Month Follow-up: Late-phase Fluorescein Angiogram Case courtesy of M Stur 6 -Month Follow-up: Late-phase Fluorescein Angiogram Case courtesy of M Stur